Leap-1030

N/A

Report date: 2026/05/26 20:00:28

Base Information

Drug NameLeap-1030
Drug Alias NameLeap1030Leap-1030
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionT lymphocytes stimulants
TargetsUpdating
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAbility Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A